Increasing Treatment Seeking Among Suicidal Veterans Calling the Crisis Line

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified May 2014 by Department of Veterans Affairs
Sponsor:
Information provided by (Responsible Party):
Department of Veterans Affairs
ClinicalTrials.gov Identifier:
NCT01771965
First received: December 21, 2012
Last updated: May 28, 2014
Last verified: May 2014
  Purpose

The goal of this research plan is to test the effectiveness of a brief, cognitive behavioral (CB) intervention to promote behavioral health treatment engagement among at-risk Veterans who call the Crisis Line but are resistant to behavioral health services.


Condition Intervention Phase
Suicide
Behavioral: CB Intervention
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Official Title: Increasing Treatment Seeking Among Suicidal Veterans Calling the Crisis Line

Further study details as provided by Department of Veterans Affairs:

Primary Outcome Measures:
  • Change in treatment engagement (number of participants entering treatment) [ Time Frame: 30 and 60 days after baseline ] [ Designated as safety issue: No ]
    The investigators will be asking about service utilization since baseline interview. Zero = no mental health treatment and 1 = received mental health treatment.


Estimated Enrollment: 80
Study Start Date: May 2014
Estimated Study Completion Date: May 2017
Estimated Primary Completion Date: May 2016 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: 1
Usual care. No intervention.
Experimental: 2
CB intervention-Cognitive Behavioral one-on-one single session administered by phone
Behavioral: CB Intervention
The Cognitive Behavioral (CB) intervention is a brief, manualized, tailored one-on-one single session lasting 45-60 minutes and administered by phone. An individual format was chosen to reduce the potential discomfort of stigma of individual concerns in the presence of others. The intervention targets a change in the beliefs that influence whether or not someone enters mental health or substance use treatment. During the session, participants will be given a brief introduction to CBT and informed that CBT is based on the theory that cognitions (i.e., thoughts/beliefs), feelings and behaviors all interact with each other;101, 102 therefore, thoughts about certain situations or things influence behavior. Since thoughts are modifiable, changing thoughts about situations may change behavior.

Detailed Description:

The goal of this research plan is to test the effectiveness of a brief, cognitive behavioral (CB) intervention to promote behavioral health treatment engagement among at-risk Veterans who call the Crisis Line but are resistant to behavioral health services. This randomized controlled trial will recruit 80 Veterans who report current suicidal ideation at the time of the Crisis Line call and are resistant to seeking behavioral health treatment. Half of the participants will receive the brief, individualized CB intervention and half will receive standardized procedures from VA's Crisis Line (i.e., usual care). The effectiveness of the intervention will be tested on 1) attitudes toward behavioral health treatment rates, and 2) initiation of and adherence to treatment (assessed by the number of sessions attended). We will also assess the impact of the intervention on suicidal ideation (SI) and explore the impact on the most common symptoms observed in Veteran suicide decedents (e.g., depression).

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

Inclusion criteria for the study are as follows:

  • individuals 18 and older who call the Veteran Crisis Line
  • have a phone number where they can be reached, be it a land line or a cell phone
  • deemed by the Crisis Line responder to be at risk for suicide, but not imminent risk
  • refuse a referral to the SPC or to a behavioral health treatment provider during the call
  • report current suicidal ideation (SI) during the call based on administration of a standard item
  • have not been in behavioral health treatment in the past. Presence of SI will be subsequently confirmed by the research assistant using the Columbia Suicide Severity Rating Scale, a validated instrument.

Exclusion Criteria:

Exclusion criteria are being judged by the Crisis Line responder to show:

  • debilitating cognitive impairment
  • active psychosis or mania
  • acute alcohol or drug intoxication
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01771965

Contacts
Contact: Elizabeth Schifano (585) 393-7968 Elizabeth.Schifano@va.gov
Contact: Kelsey Simons, PhD (585) 539-7570 kelsey.simons@va.gov

Locations
United States, New York
Canandaigua VA Medical Center, Canandaigua, NY Not yet recruiting
Canandaigua, New York, United States, 14424
Contact: Kenneth R Conner, PsyD    585-393-7548    Ken.Conner@va.gov   
United States, Vermont
White River Junction VA Medical Center, White River Junction, VT Not yet recruiting
White River Junction, Vermont, United States, 05009-0001
Contact: Elizabeth Schifano    585-393-7968    Elizabeth.Schifano@va.gov   
Principal Investigator: Tracy A Stecker, PhD         
Sponsors and Collaborators
Investigators
Principal Investigator: Tracy A Stecker, PhD White River Junction VA Medical Center, White River Junction, VT
  More Information

No publications provided

Responsible Party: Department of Veterans Affairs
ClinicalTrials.gov Identifier: NCT01771965     History of Changes
Other Study ID Numbers: IIR 11-298
Study First Received: December 21, 2012
Last Updated: May 28, 2014
Health Authority: United States: Federal Government

ClinicalTrials.gov processed this record on October 19, 2014